Efnisyfirlit

• Cover
• Title Page
• Copyright
• Dedication
• Preface
• Contents
• A Clinical Psychiatry
• 1. Examination and Diagnosis of the Psychiatric Patient
• 1.1 The Adult Patient
• PSYCHIATRIC INTERVIEW, HISTORY, AND MENTAL STATUS EXAMINATION
• PHYSICAL EXAMINATION OF THE PSYCHIATRIC PATIENT
• THE PSYCHIATRIC REPORT AND MEDICAL RECORD
• PSYCHIATRIC RATING SCALES
• CLINICAL NEUROPSYCHOLOGY AND INTELLECTUAL ASSESSMENT OF ADULTS
• PERSONALITY ASSESSMENT: ADULTS AND CHILDREN
• MEDICAL ASSESSMENT AND LABORATORY TESTING IN PSYCHIATRY
• NEUROIMAGING
• 1.2 Children and Adolescents
• CLINICAL INTERVIEWS
• DIAGNOSTIC INSTRUMENTS
• QUESTIONNAIRES AND RATING SCALES
• COMPONENTS OF THE CHILD PSYCHIATRIC EVALUATION
• RECOMMENDATIONS AND TREATMENT PLAN
• INTELLECTUAL DISABILITY PSYCHIATRIC INTERVIEW AND TESTS
• 1.3 Geriatric Patients
• PSYCHIATRIC EXAMINATION OF THE OLDER PATIENT
• EARLY DETECTION AND PREVENTION STRATEGIES
• 2. Neurodevelopmental Disorders and Other Childhood Disorders
• 2.1 Intellectual Disability
• NOMENCLATURE
• CLASSIFICATION
• DEGREES OF SEVERITY OF INTELLECTUAL DISABILITY
• CLINICAL FEATURES
• DIAGNOSIS
• DIFFERENTIAL DIAGNOSIS
• COMORBIDITY
• COURSE AND PROGNOSIS
• TREATMENT
• EPIDEMIOLOGY
• ETIOLOGY
• 2.2 Communication Disorders
• LANGUAGE DISORDER
• SPEECH SOUND DISORDER
• CHILD-ONSET FLUENCY DISORDER (STUTTERING)
• SOCIAL (PRAGMATIC) COMMUNICATION DISORDER
• UNSPECIFIED COMMUNICATION DISORDER
• 2.3 Autism Spectrum Disorder
• DIAGNOSIS AND CLINICAL FEATURES
• DIFFERENTIAL DIAGNOSIS
• COURSE AND PROGNOSIS
• TREATMENT
• EPIDEMIOLOGY
• ETIOLOGY AND PATHOGENESIS
• 2.4 Attention-Deficit/Hyperactivity Disorder
• CLINICAL FEATURES
• DIAGNOSIS
• DIFFERENTIAL DIAGNOSIS
• COURSE AND PROGNOSIS
• TREATMENT
• EPIDEMIOLOGY
• ETIOLOGY
• ADULT MANIFESTATIONS OF ADHD
• 2.5 Specific Learning Disorder
• SPECIFIC LEARNING DISORDER WITH IMPAIRMENT IN READING
• SPECIFIC LEARNING DISORDER WITH IMPAIRMENT IN MATHEMATICS
• SPECIFIC LEARNING DISORDER WITH IMPAIRMENT IN WRITTEN EXPRESSION
• 2.6 Motor Disorders
• DEVELOPMENTAL COORDINATION DISORDER
• STEREOTYPIC MOVEMENT DISORDER
• TOURETTES DISORDER
• PERSISTENT (CHRONIC) MOTOR OR VOCAL TIC DISORDER
• 2.7 Feeding and Eating Disorders of Infancy or Early Childhood
• PICA
• RUMINATION DISORDER
• AVOIDANT/RESTRICTIVE FOOD INTAKE DISORDER
• 2.8 Trauma- and Stressor-Related Disorders in Children
• REACTIVE ATTACHMENT DISORDER AND DISINHIBITED SOCIAL ENGAGEMENT DISORDER
• POSTTRAUMATIC STRESS DISORDER OF INFANCY, CHILDHOOD, AND ADOLESCENCE
• 2.9 Depressive Disorders and Suicide in Children and Adolescents
• DIAGNOSIS AND CLINICAL FEATURES
• DIFFERENTIAL DIAGNOSIS
• COURSE AND PROGNOSIS
• TREATMENT
• EPIDEMIOLOGY
• ETIOLOGY
• SUICIDE
• 2.10 Early-Onset Bipolar Disorder
• DIAGNOSIS AND CLINICAL FEATURES
• DIFFERENTIAL DIAGNOSIS
• COMORBIDITY
• COURSE AND PROGNOSIS
• TREATMENT
• EPIDEMIOLOGY
• ETIOLOGY
• 2.11 Disruptive Mood Dysregulation Disorder
• DIAGNOSIS AND CLINICAL FEATURES
• DIFFERENTIAL DIAGNOSIS
• COMORBIDITY
• COURSE AND PROGNOSIS
• TREATMENT
• EPIDEMIOLOGY
• 2.12 Disruptive Behaviors of Childhood
• OPPOSITIONAL DEFIANT DISORDER
• CONDUCT DISORDER
• 2.13 Anxiety Disorders of Infancy, Childhood, and Adolescence: Separation Anxiety Disorder, Generalized Anxiety Disorder, and Social Anxiety Disorder (Social Phobia)
• SEPARATION ANXIETY DISORDER
• GENERALIZED ANXIETY DISORDER
• SOCIAL ANXIETY DISORDER (SOCIAL PHOBIA)
• DIAGNOSIS AND CLINICAL FEATURES
• DIFFERENTIAL DIAGNOSIS
• COURSE AND PROGNOSIS
• TREATMENT
• EPIDEMIOLOGY
• ETIOLOGY
• 2.14 Selective Mutism
• DIAGNOSIS AND CLINICAL FEATURES
• DIFFERENTIAL DIAGNOSIS
• COURSE AND PROGNOSIS
• TREATMENT
• EPIDEMIOLOGY
• ETIOLOGY
• 2.15 Obsessive-Compulsive Disorder in Childhood and Adolescence
• DIAGNOSIS AND CLINICAL FEATURES
• DIFFERENTIAL DIAGNOSIS
• COURSE AND PROGNOSIS
• TREATMENT
• EPIDEMIOLOGY
• ETIOLOGY
• 2.16 Early-Onset Schizophrenia
• DIAGNOSIS AND CLINICAL FEATURES
• DIFFERENTIAL DIAGNOSIS
• COURSE AND PROGNOSIS
• TREATMENT
• EPIDEMIOLOGY
• ETIOLOGY
• ATTENUATED PSYCHOSIS SYNDROME
• 2.17 Adolescent Substance Use Disorders
• DIAGNOSIS AND CLINICAL FEATURES
• COMORBIDITY
• TREATMENT
• EPIDEMIOLOGY
• ETIOLOGY
• 3. Neurocognitive Disorders
• 3.1 Delirium
• DIAGNOSIS AND CLINICAL FEATURES
• PHYSICAL AND LABORATORY EXAMINATIONS
• DIFFERENTIAL DIAGNOSIS
• COURSE AND PROGNOSIS
• TREATMENT
• EPIDEMIOLOGY
• ETIOLOGY
• 3.2 Dementia (Major Neurocognitive Disorder)
• DIAGNOSIS AND CLINICAL FEATURES
• DIFFERENTIAL DIAGNOSIS
• COURSE AND PROGNOSIS
• TREATMENT
• EPIDEMIOLOGY
• ETIOLOGY
• 3.3 Major or Minor Neurocognitive Disorder due to Another Medical Condition (Amnestic Disorders)
• DIAGNOSIS
• CLINICAL FEATURES AND SUBTYPES
• PATHOLOGY AND LABORATORY EXAMINATION
• DIFFERENTIAL DIAGNOSIS
• COURSE AND PROGNOSIS
• TREATMENT
• EPIDEMIOLOGY
• ETIOLOGY
• 3.4 Neurocognitive and Other Psychiatric Disorders due to a General Medical Condition
• SPECIFIC DISORDERS
• 3.5 Mild Cognitive Impairment
• DEFINITION
• CLINICAL PRESENTATION
• COURSE AND PROGNOSIS
• TREATMENT
• EPIDEMIOLOGY AND ETIOLOGY OF MCI
• 4. Substance Use and Addictive Disorders
• 4.1 General Features of the Substance-Related Disorders
• THE CLINICAL PRESENTATION
• DIAGNOSIS
• COMORBIDITY
• TREATMENT APPROACH
• ETIOLOGY
• 4.2 Alcohol-Related Disorders
• DIAGNOSIS AND CLINICAL FEATURES
• COMORBIDITY
• COURSE AND PROGNOSIS
• TREATMENT OF ALCOHOL USE DISORDERS
• PATHOLOGY
• ETIOLOGY
• 4.3 Cannabis-Related Disorders
• CLINICAL FEATURES
• DIAGNOSIS
• COMORBIDITY
• TREATMENT AND REHABILITATION
• EPIDEMIOLOGY
• PATHOLOGY
• 4.4 Opioid-Related Disorders
• CLINICAL FEATURES
• COMORBIDITY
• TREATMENT AND REHABILITATION
• EPIDEMIOLOGY
• PATHOLOGY
• ETIOLOGY
• 4.5 Sedative-, Hypnotic-, or Anxiolytic-Related Disorders
• DIAGNOSIS
• TREATMENT AND REHABILITATION
• EPIDEMIOLOGY
• PATHOLOGY
• 4.6 Stimulant-Related Disorders
• CLINICAL FEATURES
• DIAGNOSIS
• COMORBIDITY
• TREATMENT AND REHABILITATION
• EPIDEMIOLOGY
• PATHOLOGY
• ETIOLOGY
• 4.7 Tobacco-Related Disorders
• CLINICAL FEATURES
• DIAGNOSIS
• TREATMENT
• EPIDEMIOLOGY
• PATHOLOGY
• 4.8 Caffeine-Related Disorders
• CLINICAL FEATURES AND DIAGNOSIS
• COMORBIDITY
• TREATMENT
• EPIDEMIOLOGY
• PATHOLOGY AND ETIOLOGY
• 4.9 Hallucinogen-Related Disorders
• CLINICAL FEATURES
• DIAGNOSIS
• TREATMENT
• EPIDEMIOLOGY
• PATHOLOGY
• 4.10 Inhalant-Related Disorders
• CLINICAL FEATURES
• DIAGNOSIS
• TREATMENT
• EPIDEMIOLOGY
• 4.11 Anabolic-Androgenic Steroid Use
• CLINICAL FEATURES AND DIAGNOSIS
• TREATMENT
• EPIDEMIOLOGY
• PATHOLOGY
• ETIOLOGY
• 4.12 Gambling Disorder
• CLINICAL FEATURES
• DIAGNOSIS
• DIFFERENTIAL DIAGNOSIS
• COMORBIDITY
• COURSE AND PROGNOSIS
• TREATMENT
• EPIDEMIOLOGY
• ETIOLOGY
• 4.13 Other Disorders Related to the Addictive Disorders
• INTERNET GAMING DISORDER
• MOBILE OR CELL PHONE COMPULSION
• REPETITIVE SELF-MUTILATION
• COMPULSIVE SEXUAL BEHAVIOR
• 5. Schizophrenia Spectrum and Other Psychotic Disorders
• THE CLINICAL PRESENTATION
• DIAGNOSIS
• OBJECTIVE TESTS FOR THE DISORDER
• DIFFERENTIAL DIAGNOSIS FOR PSYCHOTIC DISORDERS
• COMORBIDITY
• COURSE
• PROGNOSIS
• TREATMENT APPROACH
• THE EPIDEMIOLOGY OF THE DISORDERS
• THE NEUROBIOLOGY OF THE DISORDER
• THE PSYCHOLOGY OF THE DISORDER
• ETIOLOGY
• 6. Bipolar Disorders
• THE CLINICAL PRESENTATION
• DIAGNOSIS
• DIFFERENTIAL DIAGNOSIS
• COMORBIDITY
• COURSE
• PROGNOSIS
• TREATMENT APPROACH
• THE EPIDEMIOLOGY OF THE DISORDER(S)
• THE NEUROBIOLOGY OF THE DISORDER
• THE PSYCHOLOGY OF THE DISORDER
• ETIOLOGY
• 7. Depressive Disorders
• THE CLINICAL PRESENTATION
• DIAGNOSIS
• DIFFERENTIAL DIAGNOSIS
• COMORBIDITY
• COURSE
• PROGNOSIS
• TREATMENT APPROACH
• THE EPIDEMIOLOGY OF DEPRESSION
• THE NEUROBIOLOGY OF DEPRESSION
• THE PSYCHOLOGY OF DEPRESSION
• ETIOLOGY
• 8. Anxiety Disorders
• THE CLINICAL PRESENTATION
• DIAGNOSIS
• DIFFERENTIAL DIAGNOSIS
• COMORBIDITY
• COURSE
• TREATMENT APPROACH
• THE EPIDEMIOLOGY OF THE DISORDER(S)
• THE NEUROBIOLOGY OF THE DISORDER
• ETIOLOGY
• 9. Obsessive-Compulsive and Related Disorders
• THE CLINICAL PRESENTATION
• DIAGNOSIS
• DIFFERENTIAL DIAGNOSIS
• COMORBIDITY
• COURSE AND PROGNOSIS
• TREATMENT
• EPIDEMIOLOGY
• ETIOLOGY
• 10. Trauma- and Stressor-Related Disorders
• THE CLINICAL PRESENTATION
• DIAGNOSIS
• DIFFERENTIAL DIAGNOSIS FOR THE TRAUMA- AND STRESSOR-RELATED DISORDERS
• COMORBIDITY
• COURSE AND PROGNOSIS
• TREATMENT APPROACH
• EPIDEMIOLOGY
• ETIOLOGY
• 11. Dissociative Disorders
• DIAGNOSTIC AND CLINICAL FEATURES
• DEPERSONALIZATION/DEREALIZATION DISORDER
• DISSOCIATIVE IDENTITY DISORDER
• OTHER SPECIFIED OR UNSPECIFIED DISSOCIATIVE DISORDER
• COMORBIDITY
• COURSE AND PROGNOSIS
• TREATMENT
• EPIDEMIOLOGY
• ETIOLOGY
• 12. Somatic Symptom and Related Disorders
• THE CLINICAL PRESENTATION
• DIAGNOSIS
• EVALUATION OF SOMATIC SYMPTOM AND RELATED DISORDERS
• DIFFERENTIAL DIAGNOSIS
• COMORBIDITY
• COURSE AND PROGNOSIS
• TREATMENT OF SOMATIC SYMPTOM AND RELATED DISORDERS
• EPIDEMIOLOGY
• ETIOLOGY
• 13. Feeding and Eating Disorders
• CLINICAL FEATURES
• DIAGNOSIS AND CLINICAL FEATURES
• PATHOLOGY AND LABORATORY EXAMINATION
• DIFFERENTIAL DIAGNOSIS
• COMORBIDITY
• COURSE AND PROGNOSIS
• TREATMENT APPROACH
• EPIDEMIOLOGY
• ETIOLOGY
• 14. Elimination Disorders
• ENCOPRESIS
• ENURESIS
• 15. Sleep–Wake Disorders
• THE CLINICAL PRESENTATION
• DIAGNOSIS
• CLINICAL TOOLS IN SLEEP MEDICINE
• DIFFERENTIAL DIAGNOSIS
• COMORBIDITY
• TREATMENT APPROACH
• 16. Human Sexuality and Sexual Dysfunctions
• SEXUAL DYSFUNCTIONS
• PARAPHILIC DISORDERS
• SEX ADDICTION AND COMPULSIVITY
• NORMAL SEXUALITY
• 17. Gender Dysphoria, Gender Identity, and Related Conditions
• INTRODUCTION
• DIAGNOSIS AND CLINICAL FEATURES
• DIFFERENTIAL DIAGNOSIS
• COURSE AND PROGNOSIS
• COMORBIDITY
• TREATMENT
• EPIDEMIOLOGY
• ETIOLOGY
• 18. Disruptive, Impulse-Control, and Conduct Disorders
• THE CLINICAL PRESENTATION
• DIAGNOSIS
• OBJECTIVE TESTS FOR THE DISORDERS
• DIFFERENTIAL DIAGNOSIS FOR THE DISRUPTIVE AND IMPULSE-CONTROL DISORDERS
• COMORBIDITY
• COURSE AND PROGNOSIS
• TREATMENT APPROACH
• EPIDEMIOLOGY
• ETIOLOGY
• 19. Personality Disorders
• THE CLINICAL PRESENTATION
• DIAGNOSIS
• DIFFERENTIAL DIAGNOSIS
• COMORBIDITY
• COURSE AND PROGNOSIS
• TREATMENT APPROACH
• EPIDEMIOLOGY
• ETIOLOGY
• 20. Other Conditions that May be a Focus of Clinical Attention
• INTRODUCTION
• MALINGERING
• BEREAVEMENT
• OCCUPATIONAL PROBLEMS
• ADULT ANTISOCIAL BEHAVIOR
• RELIGIOUS OR SPIRITUAL PROBLEM
• ACCULTURATION PROBLEM
• PHASE OF LIFE PROBLEM
• NONCOMPLIANCE WITH TREATMENT
• RELATIONAL PROBLEMS
• B Treatment Across the Lifespan
• 21. Psychopharmacology
• 21.1 Antipsychotics
• SEROTONIN–DOPAMINE ANTAGONISTS AND SIMILARLY ACTING DRUGS (SECOND-GENERATION OR ATYPICAL ANTIPSYCHOTICS)
• DOPAMINE RECEPTOR ANTAGONISTS (FIRST-GENERATION ANTIPSYCHOTICS)
• 21.2 Antidepressants
• SELECTIVE SEROTONIN REUPTAKE INHIBITORS
• SELECTIVE SEROTONIN–NOREPINEPHRINE REUPTAKE INHIBITORS
• BUPROPION
• MIRTAZAPINE
• NEFAZODONE AND TRAZODONE
• TRICYCLICS AND TETRACYCLICS
• MONOAMINE OXIDASE INHIBITORS
• THYROID HORMONES
• NOVEL AGENTS
• 21.3 Mood Stabilizers
• LITHIUM
• VALPROATE
• LAMOTRIGINE
• CARBAMAZEPINE AND OXCARBAZEPINE
• OTHER ANTICONVULSANTS
• CALCIUM CHANNEL BLOCKERS
• 21.4 Anxiolytics
• BENZODIAZEPINES AND DRUGS ACTING ON GABA RECEPTORS
• BUSPIRONE
• β-ADRENERGIC RECEPTOR ANTAGONISTS
• BARBITURATES AND SIMILARLY ACTING DRUGS
• 21.5 Drugs Used to Treat Sleep Disorders
• NONBENZODIAZEPINE GABA AGONISTS
• MELATONIN AGONISTS: RAMELTEON AND MELATONIN
• PRAZOSIN
• 21.6 Stimulants
• STIMULANT DRUGS AND ATOMOXETINE
• ATOMOXETINE (STRATTERA)
• 21.7 Drugs Used to Treat Substance Use Disorders
• OPIOID RECEPTOR AGONISTS
• OPIOID RECEPTOR ANTAGONISTS: NALTREXONE, NALMEFENE, AND NALOXONE
• DISULFIRAM AND ACAMPROSATE
• CLONIDINE AND GUANFACINE
• 21.8 Drugs Used for Cognitive Enhancement
• CHOLINESTERASE INHIBITORS
• MEMANTINE
• 21.9 Drugs Used to Treat Sexual Disorders
• PHOSPHODIESTERASE-5 INHIBITORS
• YOHIMBINE
• 21.10 Drugs Used to Treat the Side Effects of Psychotropic Drugs
• ANTICHOLINERGIC AGENTS
• ANTIHISTAMINES
• DOPAMINE RECEPTOR AGONISTS AND PRECURSORS
• DRUGS TO TREAT PSYCHOTROPIC-INDUCED WEIGHT GAIN
• 21.11 Nutritional Supplements and Related
• NUTRITIONAL SUPPLEMENTS AND MEDICAL FOODS
• PHYTOMEDICINES
• 22. Other Somatic Therapies
• ELECTROCONVULSIVE THERAPY
• OTHER BRAIN STIMULATION METHODS
• NEUROSURGICAL TREATMENTS AND DEEP BRAIN STIMULATION
• 23. Psychotherapy
• PSYCHOANALYSIS AND PSYCHOANALYTIC PSYCHOTHERAPY
• BRIEF PSYCHODYNAMIC PSYCHOTHERAPY
• GROUP PSYCHOTHERAPY, COMBINED INDIVIDUAL AND GROUP PSYCHOTHERAPY, AND PSYCHODRAMA
• FAMILY THERAPY AND COUPLES THERAPY
• DIALECTICAL BEHAVIOR THERAPY
• BIOFEEDBACK
• COGNITIVE THERAPY
• BEHAVIOR THERAPY
• HYPNOSIS
• INTERPERSONAL THERAPY
• NARRATIVE PSYCHOTHERAPY
• COMBINED PSYCHOTHERAPY AND PHARMACOTHERAPY
• MENTALIZATION-BASED TREATMENT
• PSYCHOEDUCATIONAL INTERVENTIONS
• 24. Psychiatric Rehabilitation and Other Interventions
• PSYCHIATRIC REHABILITATION
• GENETIC COUNSELING
• 25. Consultation to Other Disciplines
• 25.1 Consultation-Liaison Psychiatry
• HISTORY
• CURRENT TRENDS
• EVALUATION PROCESS IN PSYCHOSOMATIC MEDICINE
• TREATMENTS USED IN PSYCHOSOMATIC MEDICINE
• PSYCHO-ONCOLOGY
• 25.2 Geriatric Psychiatry
• PSYCHIATRIC PROBLEMS OF OLDER PERSONS
• MENTAL DISORDERS OF OLD AGE
• SUICIDE RISK
• OTHER CONDITIONS OF OLD AGE
• SPOUSAL BEREAVEMENT
• PSYCHOPHARMACOLOGICAL TREATMENT OF GERIATRIC DISORDERS
• PSYCHOTHERAPY FOR GERIATRIC PATIENTS
• 25.3 Psychiatric Emergencies
• TREATMENT SETTINGS
• EPIDEMIOLOGY
• EVALUATION
• SPECIFIC INTERVIEW SITUATIONS
• TREATMENT OF EMERGENCIES
• PSYCHIATRIC EMERGENCIES IN CHILDREN
• 26. Level of Care
• INPATIENT ADMISSION
• PARTIAL HOSPITAL TREATMENT
• INTENSIVE OUTPATIENT TREATMENT
• OUTPATIENT CARE
• RESIDENTIAL CARE
• C Other Issues Relevant to Psychiatry
• 27. Ethics and Professionalism
• PROFESSIONAL CODES
• BASIC ETHICAL PRINCIPLES
• SPECIFIC ISSUES
• 28. Forensic and Legal Issues
• MEDICAL MALPRACTICE
• PRIVILEGE AND CONFIDENTIALITY
• HIGH-RISK CLINICAL SITUATIONS
• HOSPITALIZATION
• RIGHT TO TREATMENT
• RIGHT TO REFUSE TREATMENT
• CIVIL RIGHTS OF PATIENTS
• SECLUSION AND RESTRAINT
• INFORMED CONSENT
• CHILD CUSTODY
• TESTAMENTARY AND CONTRACTUAL CAPACITY AND COMPETENCE
• CRIMINAL LAW
• OTHER AREAS OF FORENSIC PSYCHIATRY
• 29. End-of-Life Issues and Palliative Care
• 29.1 Death, Dying, and Bereavement
• DEATH AND DYING
• BEREAVEMENT, GRIEF, AND MOURNING
• LIFE CYCLE PERSPECTIVES ABOUT BEREAVEMENT
• 29.2 Palliative Care
• PREVALENCE
• GENERAL TREATMENT PRINCIPLES
• ANXIETY IN PATIENTS WITH ADVANCED DISEASE
• DEPRESSION IN PATIENTS WITH ADVANCED DISEASE
• CONFUSIONAL STATES IN PATIENTS WITH ADVANCED DISEASE
• DISEASE-SPECIFIC CONSIDERATIONS
• PATIENT–FAMILY UNIT
• DECISION POINTS, ADVANCE DIRECTIVES, PROXIES, AND SURROGATES
• CARING FOR THE DYING PATIENT
• COMMUNICATION
• TERMINAL CARE DECISIONS
• CARING FOR THE FAMILY
• PALLIATIVE CARE
• PAIN MANAGEMENT
• PALLIATION OF OTHER SYMPTOMS
• HOSPICE CARE
• NEONATAL AND INFANT END-OF-LIFE CARE
• CHILD END-OF-LIFE CARE
• SPIRITUAL ISSUES
• ALTERNATIVE AND COMPLEMENTARY MEDICINE
• 29.3 Euthanasia and Physician-Assisted Suicide
• EUTHANASIA
• PHYSICIAN-ASSISTED SUICIDE
• FUTURE DIRECTIONS
• 30. Community Psychiatry
• INTRODUCTION
• CONTEMPORARY PUBLIC AND COMMUNITY PSYCHIATRY
• THE ROLE OF PUBLIC AND COMMUNITY PSYCHIATRY IN TWENTY-FIRST CENTURY HEALTH CARE
• 31. Global and Cultural Issues in Psychiatry
• PREVALENCE AND BURDEN OF MENTAL DISORDERS WORLDWIDE
• TREATMENT GAP AND PROJECTED POPULATION-LEVEL TREATMENT EFFECTIVENESS WORLDWIDE
• RESOURCES FOR MENTAL HEALTH CARE WORLDWIDE
• PRINCIPLES FOR MENTAL HEALTH PROGRAM DEVELOPMENT AND BARRIERS TO CHANGE WORLDWIDE
• STIGMATIZING ATTITUDES TOWARD PEOPLE WITH MENTAL DISORDERS
• RELATIONSHIPS BETWEEN MENTAL AND PHYSICAL DISEASES
• ETHICAL ISSUES IN MENTAL HEALTH CARE
• INTERNATIONAL ORGANIZATIONS ACTIVE IN THE MENTAL HEALTH FIELD
• FUTURE PERSPECTIVES
• D Contributions from the Sciences and Social Sciences to Psychiatry
• 32. Normal Development and Aging
• 32.1 Infant, Child, and Adolescent Development
• PRENATAL, INFANT, AND CHILD
• PRENATAL
• INFANCY
• TODDLER PERIOD
• PRESCHOOL PERIOD
• MIDDLE YEARS
• ADOLESCENCE
• 32.2 Adulthood
• INTRODUCTION
• YOUNG ADULTHOOD (20 TO 40 YEARS OF AGE)
• MIDDLE ADULTHOOD (40 TO 65 YEARS OF AGE)
• DIVORCE
• ADULT MATURITY
• 32.3 Old Age
• DEMOGRAPHICS
• BIOLOGY OF AGING
• STAGE THEORIES OF PERSONALITY DEVELOPMENT
• PSYCHOSOCIAL ASPECTS OF AGING
• 33. Contributions from the Neurosciences
• THE HUMAN BRAIN
• FUNCTIONAL NEUROANATOMY
• NEURAL DEVELOPMENT AND NEUROGENESIS
• NEUROPHYSIOLOGY AND NEUROCHEMISTRY
• PSYCHONEUROENDOCRINOLOGY
• IMMUNE SYSTEM AND CENTRAL NERVOUS SYSTEM INTERACTIONS
• NEUROGENETICS
• APPLIED ELECTROPHYSIOLOGY
• CHRONOBIOLOGY
• 34. Contributions from the Behavioral and Social Sciences
• 34.1 Contributions from the Psychosocial Sciences
• JEAN PIAGET AND COGNITIVE DEVELOPMENT
• ATTACHMENT THEORY
• LEARNING THEORY
• BIOLOGY OF MEMORY
• MULTIPLE TYPES OF MEMORY
• NEUROIMAGING AND MEMORY
• SLEEP AND MEMORY
• ASSESSMENT OF MEMORY FUNCTIONS
• IMPLICATIONS
• 34.2 Normality and Mental Health
• DEFINING MENTAL HEALTH
• MODELS OF MENTAL HEALTH
• 34.3 Contributions from the Sociocultural Sciences
• SOCIOBIOLOGY AND ETHOLOGY
• TRANSCULTURAL PSYCHIATRY
• CULTURE-BOUND SYNDROMES
• 34.4 Theories of Personality and Psychopathology
• SIGMUND FREUD: FOUNDER OF CLASSIC PSYCHOANALYSIS
• ERIK H. ERIKSON
• OTHER PSYCHODYNAMIC SCHOOLS
• POSITIVE PSYCHOLOGY
• 35. A Brief History of Psychiatry
• PSYCHIATRY BEFORE THE MODERN ERA
• PSYCHIATRY IN THE MODERN AGE
• DEINSTITUTIONALIZATION
• THE CLASSIFICATION OF PSYCHIATRIC DISORDERS
• LOOKING TO THE FUTURE
• Glossary of Terms Relating to Signs and Symptoms
• Index